Novo Nordisk Pharma (Taiwan) Ltd.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
Healthcare Asia Pharma Awards 2023 Winner: Novo Nordisk Pharma (Taiwan) Ltd.
Healthcare Asia Pharma Awards 2023 Winner: Novo Nordisk Pharma (Taiwan) Ltd.
Novo Nordisk Pharma (Taiwan) Ltd. wins the ESG Programme of the Year - Taiwan award at the Healthcare Asia Pharma Awards 2023.
Novo Nordisk Pharma Taiwan awarded ESG Program of the Year - Taiwan by the Healthcare Asia Pharma Awards
The company's Corporate Social Responsibility awareness programme aims to give back to local communities and take action for environmental improvement.
Most Read
1. Hong Kong seeks prescription for nursing shortage 2. ASEAN medical tourism set to outpace global revenue growth 3. OUE Healthcare subsidiary secures majority stake in Rehab Matters 4. Thomson and Monash University Malaysia partner for joint research 5. Sunway Medical Centre Ipoh to open in Q2 2025Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
The trade show, which was held in Singapore, successfully brought together over 13,000 visionary digital health innovators, government leaders, and industry pioneers from the medical and healthcare sectors.
